Smart Inhaler Market Worth USD 2 Billion by 2028, Says Global Market Insights Inc.

Growth of population living in underdeveloped and developing economies highly prone to indoor air pollutants. Additionally, people living in poor housing and neighborhoods are susceptible to several respiratory conditions, including COPD and asthma. In addition, the extensive use of portable stoves and kerosene lamps for heating and cooking in low- and middle-income countries and poor ventilation lead to the inhalation of particulates.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3994

The growing focus on technological developments in smart inhalers will provide substantial growth opportunities to the market. In recent years, medical professionals often lacked the medical information and tools to understand the patient’s health condition. This has increased the need for smart inhalers in respiratory disease management to provide new ways to provide patient self-management. The increased availability of connected inhalers offers many advantages through the miniaturization of sensors such as ease of use, tracking of medical records, accurate dose monitoring and many others.

Some major findings of the Smart Inhalers Market report include:

  1. Rising incidence of environmental and genetic risk factors that lead to asthma or COPD will propel the expansion of the industry.
  2. Growing strategic initiatives between digital and pharmaceutical companies for the development of new products are expected to proliferate the market revenue.
  3. The increasing availability and accessibility of products along with the expansion of healthcare facilities will accelerate the market forecast.

Browse key industry information spread over 192 pages with 162 market data tables and 14 report figures and graphs, “Smart Inhalers Market Size by Product (Dry Powder Inhaler (DPI) Smart Inhalers, Metered Dose Inhaler (MDI) Smart Inhalers, by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD) ), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share and Forecast, 2022-2028” in detail with the table of contents: https://www.gminsights.com/industry-analysis/smart-inhalers-market

The metered-dose inhaler-based smart inhaler segment held over 35% market share in 2021 and is expected to register a significant CAGR through 2028 owing to the growing need for precise drug delivery systems for treatment effective against respiratory diseases. Additionally, these devices are used to monitor and control the precise dose of dispersed medications as per the needs of the patient. Increasing R&D activities for new product development and improving the availability of MDI-based smart inhalers will increase the smart inhaler market revenue.

The e-commerce segment is expected to grow at a CAGR of 7.7% over the forecast period owing to the growing adoption of e-prescriptions by healthcare professionals in developing and developed countries. Additionally, the COVID-19 pandemic has boosted the adoption of online pharmacies due to movement restrictions. Thus, increased patient preference for e-commerce platforms is expected to fuel the smart inhaler market landscape.

Asia Pacific The smart inhaler market held around 22% revenue share in 2021 and will significantly increase over the estimated period, driven by a large patient population in the region. Moreover, the increasing inclination of patients towards integrated devices of advanced technology for better efficiency will strengthen the overall growth of the industry. the development of health infrastructure and the increase in health expenditure will propel the expansion of the regional industry.

Request to customize this research report @ https://www.gminsights.com/roc/3994

Some of the major key business players operating in the smart inhaler industry include Adherium, Propeller Health, Nemera, GlaxoSmithKline Plc., Novartis AG, Aptar Group Inc., AstraZeneca Plc, Findair Sp. Zoo, BioCorp, Zeolr Technologies Pvt Ltd., Vectura Group Plc., Teva Pharmaceutical Industries Ltd. and Boehringer Ingelheim International GmbH

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, in the United States, is a global provider of market research and consulting services, offering syndicated and custom research reports as well as growth consulting services. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid in strategic decision-making. These comprehensive reports are designed using proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact us:

Arun Hegde
business sales, UNITED STATES
Global Market Insights Inc.
Call: 1-302-846-7766
Free: 1-888-689-0688
E-mail: [email protected]

SOURCE Global Market Insights Inc.